Key highlights Rybelsus can be effective for blood sugar control in patients with type 2 diabetes, but the medication has potential side effects
Increased prescription of GLP-1 drugs for both diabetes and obesity was accompanied by nutritional counselling, expanding demand for high-protein, fiber-enriched formulations
[3] Hypothalamic-Pituitary-Adrenal (HPA) Axis Modulation : DSIP has been observed to attenuate stress-induced corticotropin-releasing hormone (CRH) activity, potentially reducing systemic cortisol release
For employers and health plans, this translates into improved adherence, reduced discontinuation, and better clinical and financial outcomes
Front Endocrinol (Lausanne) (2019) 10:155
AOXs are not regulated as pharmaceutical drugs, thus allowing their utilization without prescription